Munich - Delayed Quote EUR
Iovance Biotherapeutics Inc (2LB.MU)
1.9402
+0.1806
+(10.26%)
As of 8:00:26 AM GMT+2. Market Open.
Key Executives
Key Executives Information Not Available
Iovance Biotherapeutics Inc
Profile Information Not Available
Description
Description Information Not Available
Corporate Governance
Iovance Biotherapeutics Inc’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
August 6, 2025 at 8:00 PM UTC - August 11, 2025 at 8:00 PM UTC
Iovance Biotherapeutics Inc Earnings Date
Recent Events
Recent Events Information Not Available
Related Tickers
NXOA.BE Nicox SA
0.2305
+1.32%
5CV.HA CureVac NV
3.8220
-1.80%
ABRT.CN Albert Labs International Corp.
0.0050
0.00%
BT1.BE Bone Therapeutics SA
0.0022
+4.76%
P0F.F Egetis Therapeutics AB (publ)
0.3875
+5.01%
300759.SZ Pharmaron Beijing Co., Ltd.
25.19
+2.77%
AYJ.HA Valneva SE
2.6820
+0.15%
ALINT.PA IntegraGen SA
0.5000
-3.85%
AB3A.MU Sarepta Therapeutics Inc
34.95
-0.71%
W1H.MU Onco-Innovations Ltd
0.9800
-0.25%